“…Nasal insufflation with chemokines, such as IL-8, 26 eotaxin, 27 and regulated on activation normally T-cell expressed and secreted (RANTES), 28 has also been used to evaluate the effect and time course of their effect on cell recruitment into the nasal lumen. Studies have also been undertaken to investigate the effects of non-IgE-related stimuli, such as hyperosmolar challenge, aspirin, and sodium metabisulfite, on mediator release within the nose, [29][30][31][32] and with or without therapeutic intervention, to gain insight into the magnitude of effect and mechanism of action of differing pharmacologic modalities on cell recruitment, cell activation, and induced vascular permeability. [33][34][35][36][37][38][39][40][41] Although these approaches have been widely used in the limited research setting, they have been less widely applied as a means of objectively monitoring nasal disease in the clinical trial setting.…”